Advances in Hematological Malignancies
Recent decades have witnessed remarkable strides in the domain of hematological malignancies. Novel approaches such as targeted therapy, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative strategies, offering hope for more effective treat